| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PARR | United States | $56.94 | $2,443,066,000.00 | Buy | 6 | 2000 |
#2 | INVA | United States | $21.69 | $217,217,000.00 | Buy | 5 | 2000 |
#3 | EQT | United States | $55.01 | $8,644,211,000.00 | Buy | 21 | 1994 |
#4 | NFG | United States | $77.92 | $2,277,541,000.00 | Buy | 4 | 1997 |
#5 | CVNA | United States | $72.44 | $20,322,000,000.00 | Buy | 24 | 2017 |
#6 | TMDX | United States | $67.10 | $605,494,000.00 | Buy | 9 | 2019 |
#7 | DEC | United States | $14.52 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#8 | TBPH | United States | $16.18 | $15,386,000.00 | Buy | 6 | 2013 |
#9 | KNSA | United Kingdom | $49.48 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#10 | VIAV | United States | $46.53 | $1,084,300,000.00 | Strong Buy | 8 | 1996 |
#11 | EYE | United States | $16.95 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#12 | VTR | United States | $84.05 | $5,833,980,000.00 | Buy | 13 | 2005 |
#13 | AORT | United States | $22.90 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#14 | KNTK | United States | $45.90 | $160,617,000.00 | Buy | 12 | 2017 |
#15 | CALX | United States | $39.41 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#16 | APEI | United States | $50.12 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#17 | SWX | United States | $86.20 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#18 | NVST | United States | $23.57 | $2,566,500,000.00 | Buy | 13 | 2019 |
#19 | PUMP | United States | $15.09 | $1,269,158,000.00 | Buy | 7 | 2017 |
#20 | ALHC | United States | $15.53 | $3,948,719,000.00 | Buy | 8 | 2021 |
#21 | NMRK | United States | $14.21 | $3,294,024,000.00 | Buy | 5 | 2017 |
#22 | OMER | United States | $10.81 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#23 | ANAB | United States | $55.80 | $234,603,000.00 | Buy | 12 | 2015 |
#24 | PTEN | United States | $11.19 | $4,826,624,000.00 | Buy | 10 | 1995 |
#25 | CCK | United States | $95.85 | $11,665,000,000.00 | Buy | 16 | 2003 |
#26 | REPX | United States | $33.99 | $3,038,000.00 | Strong Buy | 4 | 2003 |
#27 | AROC | United States | $33.76 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#28 | PRVA | United States | $21.77 | $2,122,842,000.00 | Buy | 12 | 2021 |
#29 | LASR | United States | $72.93 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#30 | TW | United States | $99.27 | $892,659,000.00 | Buy | 12 | 2019 |
#31 | KGS | United States | $67.26 | $1,308,100,000.00 | Strong Buy | 7 | 2023 |
#32 | BSX | United States | $48.98 | $9,076,000,000.00 | Strong Buy | 22 | 2010 |
#33 | CSV | United States | $42.18 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#34 | SDRL | United States | $47.66 | $1,437,000,000.00 | Buy | 4 | 2018 |
#35 | HG | Bermuda | $30.08 | $2,905,524,000.00 | Buy | 8 | 2023 |
#36 | PAY | United States | $23.20 | $1,196,507,000.00 | Buy | 8 | 2021 |
#37 | CRVS | United States | $12.11 | $0.00 | Strong Buy | 6 | 2016 |
#38 | USFD | United States | $81.67 | $39,424,000,000.00 | Buy | 11 | 2016 |
#39 | PHAT | United States | $10.19 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#40 | BFAM | United States | $62.96 | $1,903,182,000.00 | Buy | 7 | 2012 |
#41 | ERAS | United States | $12.29 | $0.00 | Strong Buy | 12 | 2021 |
#42 | PPL | United States | $35.28 | $9,042,000,000.00 | Buy | 13 | 2007 |
#43 | MDT | Ireland | $75.20 | $33,537,000,000.00 | Buy | 21 | 2014 |
#44 | LMAT | United States | $95.14 | $249,602,000.00 | Buy | 5 | 2006 |
#45 | ENTA | United States | $13.23 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#46 | TNGX | United States | $20.43 | $62,384,000.00 | Strong Buy | 10 | 2020 |
#47 | CE | United States | $53.32 | $9,544,000,000.00 | Buy | 14 | 2004 |
#48 | FTI | United States | $67.83 | $9,932,600,000.00 | Buy | 13 | 2016 |
#49 | NI | United States | $46.52 | $0.00 | Buy | 10 | 2018 |
#50 | SBRA | United States | $20.03 | $774,632,000.00 | Buy | 8 | 2010 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 29, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.